Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular tranexamic acid for blood loss reduction in total hip arthroplasty
IRCT20260412069056N1Phase 3Recruiting
- Sponsor
- Urmia University of Medical Sciences
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tranexamic acid in Bleeding (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoint: Postoperative blood loss. Started Jun 2026; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
Bleeding
Beyond the preview
Go deeper on IRCT20260412069056N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260412069056N1.